GSK plc Ordinary Shares Admission to Trading

GSK plc has notified the market of the admission of ordinary shares to trading on the London Stock Exchange's Main Market. This admission, covering 45,273 ordinary shares of 31¼ pence each (ISIN: GB00BN7SWP63), is in connection with the "GlaxoSmithKline plc Share Save Plan 2022". These shares are fully fungible with existing ordinary shares. The total number of ordinary shares admitted to trading following this notification is 4,316,221,551. The notification covers the period from March 27, 2026, to May 22, 2026. GSK plc is a global biopharma company. The filing was issued on May 26, 2026.